Cargando…

Selective COX-2 inhibitors do not increase gastrointestinal reactions after colorectal cancer surgery: a systematic review and meta-analysis

BACKGROUND: The effectiveness of selective COX-2 inhibitors in preventing colorectal cancer recurrence has been demonstrated, however it is unknown how safe and successful they will be over the long term. As a result, we looked at the efficacy, safety, and consequences of adding COX-2 inhibitors to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ting, Liu, Cheng-Jiang, Yin, Xiaoming, Tang, WenJuan, Yin, LanFang, Bai, Hui, Liu, FangFang, Wang, Dan, Li, YiLei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426080/ https://www.ncbi.nlm.nih.gov/pubmed/37580670 http://dx.doi.org/10.1186/s12876-023-02918-w

Ejemplares similares

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs
por: Scheiman, James M, et al.
Publicado: (2005)

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2
por: Li, Xia, et al.
Publicado: (2018)

Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database
por: HUANG, Sifu, et al.
Publicado: (2021)

COX-2 Inhibitors and Gastric Cancer
por: Wang, Zhen, et al.
Publicado: (2014)

Anaphylaxis to selective COX-2 inhibitors: an unexpected culprit
por: Dias de Castro, Eunice, et al.
Publicado: (2015)

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury
por: Yang, Man, et al.
Publicado: (2015)

JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats
por: Kobayashi, Hirotoshi, et al.
Publicado: (2005)

Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor
por: Galamb, O, et al.
Publicado: (2010)

JMJD2B is required for Helicobacter pylori-induced gastric carcinogenesis via regulating COX-2 expression
por: Han, Fengjuan, et al.
Publicado: (2016)

Ensembling Variable Selectors by Stability Selection for the Cox Model
por: Yin, Qing-Yan, et al.
Publicado: (2017)

Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?
por: Ostrowski, J, et al.
Publicado: (2003)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

Melatonin, a novel selective ATF-6 inhibitor, induces human hepatoma cell apoptosis through COX-2 downregulation
por: Bu, Li-Jia, et al.
Publicado: (2017)

COX-2 overexpression increases malignant potential of human glioma cells through Id1
por: Xu, Kaiming, et al.
Publicado: (2013)

Do metabolic factors increase the risk of thyroid cancer? a Mendelian randomization study
por: Liang, Weiwei, et al.
Publicado: (2023)

Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors
por: Badrey, Mohamed G., et al.
Publicado: (2015)

Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2017)

Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis
por: Zhu, Xi-Tian, et al.
Publicado: (2018)

Comparison of Absolute Expression and Turnover Number of COX-1 and COX-2 in Human and Rodent Cells and Tissues
por: Li, Li, et al.
Publicado: (2022)

Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs
por: Stockl, Karen, et al.
Publicado: (2005)

Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population
por: Zhao, Lei, et al.
Publicado: (2019)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

Adverse Effects of COX-2 Inhibitors
por: Sharma, Jagdish N., et al.
Publicado: (2005)

Binding Energy Calculation of Patchouli Alcohol Isomer Cyclooxygenase Complexes Suggested as COX-1/COX-2 Selective Inhibitor
por: Raharjo, Sentot Joko, et al.
Publicado: (2014)

Nursing Value Analysis and Risk Assessment of Acute Gastrointestinal Bleeding Using Multiagent Reinforcement Learning Algorithm
por: Liu, Fang, et al.
Publicado: (2022)

COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer
por: Yao, M, et al.
Publicado: (2002)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

Selective COX-2 inhibitor ameliorates osteoarthritis by repressing apoptosis of chondrocyte
por: Ou, Yunsheng, et al.
Publicado: (2012)

Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships
por: Zarghi, Afshin, et al.
Publicado: (2011)

Mechanism of Pyrolysis Reaction of Al-Rich Al/PTFE/TiH(2) Active Material
por: Wang, Yilei, et al.
Publicado: (2021)

YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
por: Li, Wei, et al.
Publicado: (2017)

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
por: Moussa, Nathalie, et al.
Publicado: (2023)

Flavonoids: Antiplatelet Effect as Inhibitors of COX-1
por: Zaragozá, Cristina, et al.
Publicado: (2022)

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
por: Wang, Dongxu, et al.
Publicado: (2019)

COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients
por: Hochberg, Marc C
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_as8e8rvn1cvbf59qv35ka3ribi